Navigation Links
Lung cancer conference to focus on new diagnostic techniques, potential treatments

SAN DIEGO -- Lung cancer is the most commonly diagnosed cancer in the United States and often the most fatal unless caught early, but scientists are working on ways to improve their understanding of the disease.

Several hundred of scientists will gather in San Diego at the San Diego Marriott Marquis & Marina during Jan. 8-11, 2012, for the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine.

The conference is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.

Media are welcome to attend the conference and can register by contacting Jeremy Moore at

The conference will host a media briefing, entitled "Lung Cancer Diagnosis: Pitfalls, Challenges and the Path Ahead," on Tuesday, Jan. 10 at 1:00 p.m. PT (4:00 p.m. ET). The briefing will be held in the Atlanta/Chicago room of the San Diego Marriott Marquis & Marina.

The following leaders in lung cancer are scheduled to speak at the press conference:

  • Roy Herbst, M.D., Ph.D., chief of medical oncology and associate director for translational research at the Yale Cancer Center;
  • David P. Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research, director of the Specialized Program of Research Excellence in Lung Cancer and co-leader of the Thoracic/Head and Neck Research Program at the Vanderbilt-Ingram Cancer Center; and
  • Paul A. Bunn, M.D., professor and James Dudley chair in cancer research at the University of Colorado School of Medicine.

Reporters who cannot attend in person can participate using the following information:

U.S./Canada (Toll Free): 888-647-7462

International (Toll): 201-604-0169

Conference leaders have also designated the following research as newsworthy:

  • Estrogen-Targeting Drug Combo May Help Prevent Lung Cancer
  • Researchers Map Potential Genetic Origins, Pathways of Lung Cancer in Never-Smokers
  • Ganetespib Showed Activity in KRAS-Mutant NSCLC as Monotherapy and in Combinations
  • Precancer Markers Identified in Airway Epithelium Cells of Healthy Smokers
  • Sorafenib Effective in Patients With Non-Small Cell Lung Cancer, but Low Survival Rates Reported
  • Sensitive Detection Method Analyzes Circulating Tumor Cells in Patients With Lung Cancer
  • Genetic Composition of Multicentric Lung Tumors Appears to be Similar

Contact: Jeremy Moore
American Association for Cancer Research

Related biology news :

1. MU researchers photoacoustic device finds cancer cells before they become tumors
2. New stage in fighting pancreatic cancer
3. Gene identified in increasing pancreatic cancer risk
4. Cleveland Clinic researcher discovers genetic cause of thyroid cancer
5. Penn engineers develop more effective MRI contrast agent for cancer detection
6. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
7. Potential anti-cancer treatment method wins Kaye Award
8. Wayne State study finds soybean compounds enhances effects of cancer radiotherapy
9. Cancer from fetal exposure to carcinogens depends on dose, timing
10. AACR & IASLC to host molecular origins of lung cancer conference
11. London researchers lead innovative new cancer treatment study
Post Your Comments:
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology: